Pacific Biosciences Of California | PACB - Current Assets

Stock Price
1.72
Daily Change
0.03 1.78%
Monthly
23.74%
Yearly
50.88%
Q2 Forecast
1.65

Pacific Biosciences Of California reported $375.05M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Agilent USD 4.62B 21M Dec/2025
Bruker USD 2.21B 138.1M Dec/2025
Danaher USD 12.76B 3.15B Dec/2025
General Electric Aerospace USD 40.6B 522M Dec/2025
Illumina USD 3.29B 493M Dec/2025
Myriad Genetics USD 332.6M 12.2M Dec/2025
Pacific Biosciences Of California USD 375.05M 19.18M Dec/2025
Quidel USD 1.45B 80.6M Dec/2025
Revvity USD 2.24B 95.96M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Standard Biotools USD 454.26M 18.18M Dec/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
Waters USD 1.99B 69.86M Dec/2025